Selective Ghrelin Receptor Agonist (GHRP)

Ipamorelin (10mg) is supplied in Australia by Aussie Peptides with fast domestic shipping to all states and territories.

Ipamorelin is a selective ghrelin receptor (GHS-R1a) agonist studied for pulsatile growth hormone release that mimics the body's natural GH release pattern. Unlike earlier secretagogues (GHRP-2, GHRP-6), Ipamorelin's receptor selectivity is associated with minimal cortisol and prolactin elevation in research models.

Ipamorelin is commonly studied alongside CJC-1295 (no DAC) for synergistic activation of complementary pathways: GHRH-receptor stimulation plus ghrelin-receptor stimulation.

Key Research Areas

• Pulsatile GH Release — Triggers pituitary GH pulses without significant cortisol or prolactin elevation

• Body Composition — GH/IGF-1 axis studied for protein synthesis and lean mass research

• Fat Mobilisation — GH-mediated lipolysis studied for visceral adipose tissue reduction

• Tissue Repair — Studied for connective tissue, muscle, and joint repair via GH signalling

• Sleep Architecture — GH release is nocturnal; pulse-pattern alignment studied in sleep research

• Age-Related GH Decline — Studied for restoring pulsatile GH secretion in aged models

Supplied as lyophilized powder, verified by HPLC and mass spectrometry. 10mg per vial. Fast domestic shipping across Australia, with batch-specific CoA information available in our CoA Library.

⚠ For in-vitro research and laboratory use only. Not for human consumption.